Chestnut Hill, MA, United States of America

Robert S Kauffman

This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Other. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert S Kauffman. Retrieved from https://idiyas.com/inventor/robert-s-kauffman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,570 
Other
 patents

Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Robert S. Kauffman

Introduction

Robert S. Kauffman is an accomplished inventor based in Chestnut Hill, MA (US). He has made significant contributions to the field of antiviral therapies, particularly in the treatment of Hepatitis C infections. His innovative approach combines various therapeutic agents to enhance treatment efficacy.

Latest Patents

Kauffman's most notable patent is titled "Therapeutic regimen comprising PEG-interferon, ribavirin and VX-950 for the treatment of hepatitis." This invention focuses on antiviral therapies and compositions aimed at treating or preventing Hepatitis C infections in patients. It also encompasses methods and kits that include compositions and dosage forms for effective treatment.

Career Highlights

Throughout his career, Kauffman has demonstrated a commitment to advancing medical science through his inventions. His work has been pivotal in developing new therapeutic regimens that improve patient outcomes in the fight against viral infections.

Collaborations

Kauffman has collaborated with notable professionals in his field, including Cyril Jean Camille Titeux and Ramon Polo. These partnerships have contributed to the development and refinement of his innovative therapies.

Conclusion

Robert S. Kauffman's contributions to antiviral therapy exemplify the impact of innovation in medicine. His work continues to influence the treatment of Hepatitis C, showcasing the importance of research and collaboration in advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…